154 related articles for article (PubMed ID: 21320469)
21. PRL-3 phosphatase is implicated in ovarian cancer growth.
Polato F; Codegoni A; Fruscio R; Perego P; Mangioni C; Saha S; Bardelli A; Broggini M
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6835-9. PubMed ID: 16203771
[TBL] [Abstract][Full Text] [Related]
22. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
23. Hsp90-mediated inhibition of FKBP38 regulates apoptosis in neuroblastoma cells.
Erdmann F; Jarczowski F; Weiwad M; Fischer G; Edlich F
FEBS Lett; 2007 Dec; 581(29):5709-14. PubMed ID: 18036348
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma.
Zhao WB; Li Y; Liu X; Zhang LY; Wang X
Int J Mol Med; 2008 Aug; 22(2):187-92. PubMed ID: 18636172
[TBL] [Abstract][Full Text] [Related]
25. [Expression of phosphatase of regenerating liver-3 mRNA and its clinical implications in human colorectal carcinoma].
Zhao GP; Zhou ZG; Lei WZ; Yu YY; Zheng XL; Gao HK
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):237-40. PubMed ID: 16167237
[TBL] [Abstract][Full Text] [Related]
26. Emodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity.
Han YM; Lee SK; Jeong DG; Ryu SE; Han DC; Kim DK; Kwon BM
Bioorg Med Chem Lett; 2012 Jan; 22(1):323-6. PubMed ID: 22137788
[TBL] [Abstract][Full Text] [Related]
27. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis.
Shirane M; Nakayama KI
Nat Cell Biol; 2003 Jan; 5(1):28-37. PubMed ID: 12510191
[TBL] [Abstract][Full Text] [Related]
28. The phosphatase of regenerating liver 3 (PRL-3) promotes cell migration through Arf-activity-dependent stimulation of integrin α5 recycling.
Krndija D; Münzberg C; Maass U; Hafner M; Adler G; Kestler HA; Seufferlein T; Oswald F; von Wichert G
J Cell Sci; 2012 Aug; 125(Pt 16):3883-92. PubMed ID: 22595524
[TBL] [Abstract][Full Text] [Related]
29. Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion.
Sun JP; Wang WQ; Yang H; Liu S; Liang F; Fedorov AA; Almo SC; Zhang ZY
Biochemistry; 2005 Sep; 44(36):12009-21. PubMed ID: 16142898
[TBL] [Abstract][Full Text] [Related]
30. Interaction of presenilins with FKBP38 promotes apoptosis by reducing mitochondrial Bcl-2.
Wang HQ; Nakaya Y; Du Z; Yamane T; Shirane M; Kudo T; Takeda M; Takebayashi K; Noda Y; Nakayama KI; Nishimura M
Hum Mol Genet; 2005 Jul; 14(13):1889-902. PubMed ID: 15905180
[TBL] [Abstract][Full Text] [Related]
31. A nuclear FK506-binding protein is a histone chaperone regulating rDNA silencing.
Kuzuhara T; Horikoshi M
Nat Struct Mol Biol; 2004 Mar; 11(3):275-83. PubMed ID: 14981505
[TBL] [Abstract][Full Text] [Related]
32. FKBP38-Bcl-2 interaction: a novel link to chemoresistance.
Choi BH; Yoon HS
Curr Opin Pharmacol; 2011 Aug; 11(4):354-9. PubMed ID: 21571591
[TBL] [Abstract][Full Text] [Related]
33. An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells.
Wang L; Shen Y; Song R; Sun Y; Xu J; Xu Q
Mol Pharmacol; 2009 Dec; 76(6):1238-45. PubMed ID: 19779032
[TBL] [Abstract][Full Text] [Related]
34. LEO1 is regulated by PRL-3 and mediates its oncogenic properties in acute myelogenous leukemia.
Chong PS; Zhou J; Cheong LL; Liu SC; Qian J; Guo T; Sze SK; Zeng Q; Chng WJ
Cancer Res; 2014 Jun; 74(11):3043-53. PubMed ID: 24686170
[TBL] [Abstract][Full Text] [Related]
35. Too much of a good thing: the Prl-3 in p53's oyster.
Hinds PW
Mol Cell; 2008 May; 30(3):260-1. PubMed ID: 18471970
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory activities of anthraquinones from Rubia akane on phosphatase regenerating liver-3.
Moon MK; Han YM; Lee YJ; Lee LH; Yang JH; Kwon BM; Kim DK
Arch Pharm Res; 2010 Nov; 33(11):1747-51. PubMed ID: 21116777
[TBL] [Abstract][Full Text] [Related]
37. Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression.
Mizuuchi E; Semba S; Kodama Y; Yokozaki H
Int J Cancer; 2009 Apr; 124(8):1802-10. PubMed ID: 19115206
[TBL] [Abstract][Full Text] [Related]
38. PRL-3 Promotes Ubiquitination and Degradation of AURKA and Colorectal Cancer Progression via Dephosphorylation of FZR1.
Zhang C; Qu L; Lian S; Meng L; Min L; Liu J; Song Q; Shen L; Shou C
Cancer Res; 2019 Mar; 79(5):928-940. PubMed ID: 30498084
[TBL] [Abstract][Full Text] [Related]
39. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
[TBL] [Abstract][Full Text] [Related]
40. New structural aspects of FKBP38 activation.
Maestre-Martínez M; Haupt K; Edlich F; Jahreis G; Jarczowski F; Erdmann F; Fischer G; Lücke C
Biol Chem; 2010 Oct; 391(10):1157-67. PubMed ID: 20707607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
